Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms

Name: Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms
Start: 2027-03-17T10:00
End: 2027-03-17T10:30
Location: San Diego Convention Center

BPI West 2027 · 17 March 2027 · 10:00–10:30

Product Development of a Phase III (and Beyond) Parkinson’s Allogeneic Cell Therapy using Process and Analytic Platforms was a session at BPI West 2027 on 17 March 2027 in San Diego, with 1 speaker on record.

Speakers

Jason Dowd, Ph.D., MBA — Speaker Global Lead Cell Therapy Platform, Bayer